Table 1.
Drug Resistance and Cross Resistance in Staphylococcus aureus Positive Specimens Taken from Skin Lesions that Required Incision and Drainage of HIV Positive Patients
| Column A Drug (% resistant) |
Column B Penicillin G (n=77) |
Column C Oxacillin (n=77) |
Column D Erythromycin (n=77) |
Column E Cephazolin (n=77) |
Column F Ciprofloxacin (n=73) |
Column G Clindamycin (n=58) |
Column H Tetracycline (n=75) |
Column I TMP/SMX* Rifampin Vancomycin (n=77) |
|---|---|---|---|---|---|---|---|---|
| Penicillin G (93.5%) |
- | 88.9% | 32.1% | 90.3% | 97.4% | 32.1% | 91.7% | 0% |
| Oxacillin (87.0%) |
88.9% | - | 34.7% | 97.0% | 89.5% | 34.7% | 91.7% | 0% |
| Oxacillin and Penicillin G (85.7%) |
- | - | 93.9 | 98.5% | 54.8% | 35.4% | 16.7% | 0% |
| Erythromycin (84.4%) |
32.1% | 34.7% | - | 93.8% | 50.0% | 37.0% | 45.5% | 0% |
| Cephazolin (84.4%) |
90.3% | 97.0% | 93.8% | - | 89.5% | 35.4% | 91.7% | 0% |
| Ciprofloxacin (52.2%) |
97.4% | 89.5% | 50.0% | 89.5% | - | 50.0% | 26.3% | 0% |
| Clindamycin (29.3%) |
32.1% | 34.7% | 37.0% | 35.4% | 50.0% | - | 45.5% | 0% |
| Tetracycline (15.6%) |
91.7% | 91.7% | 45.5% | 91.7% | 26.3% | 45.5% | - | 0% |
| TMP/SMX* Rifampin Vancomycin (0%) |
0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
*
Trimethoprim-sulfamethoxazole